Using vaccines to impart a long-term response in lenalidomide-treated MM
Ivan Marques Borrello
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
Venetoclax combination therapy for relapsed CLL
The future of lymphoma treatment – combining new therapies with molecular diagnosis
CTL019 in pediatric and young adult relapsed/refractory acute lymphoblastic leukemia (ALL) patients